🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase III, multicenter, open-label, randomized controlled trial. ...
Status
Recruiting
Location
Henan Cancer Hospital
Start Date
2026-06-16
Trial ID
NCT07629817
This is a multicenter, single-arm, phase II clinical study evaluating the e...
Status
Enrolling By Invitation
Location
The First People's Hospital of Foshan
Start Date
2026-04-20
Trial ID
NCT07618624
DELTA-2 is a phase 1 clinical trial to evaluate the safety, feasibility, an...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-08
Trial ID
NCT05393635
Treatments Being Tested
Chemotherapeutic agents exert significant immunomodulatory effects by influ...
Status
Recruiting
Location
the First Affiliated Hospital of Zhengzhou University
Start Date
2025-06-01
Trial ID
NCT06896422
Treatments Being Tested
This was an open-label, nonrandomized, Phase 1/2 study designed to determin...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2017-05-02
Trial ID
NCT03085914
This is a multicenter, prospective, single-arm, phase 2 clinical trial desi...
Status
Recruiting
Location
Anhui Provincial Cancer Hospital
Start Date
2024-09-12
Trial ID
NCT06288360
Treatments Being Tested
This study is a single-center, randomized controlled, phase II clinical tri...
Status
Unknown
Location
Multiple Locations
Start Date
2020-03-01
Trial ID
NCT04252365
Treatments Being Tested
This randomized controlled trial investigated the efficacy and safety of ar...
Status
Completed
Location
the First Hospital of Hebei Medical University
Start Date
2020-12-01
Trial ID
NCT07053215
Treatments Being Tested
This study aims to investigate toripalimab with chemotherapy in participant...
Status
Recruiting
Location
University of Arkansas for Medical Sciences
Start Date
2024-11-01
Trial ID
NCT06457503
Treatments Being Tested
The main goal of this research study is to determine how nivolumab and nivo...
Status
Completed
Location
UPMC Hillman Cancer Center
Start Date
2020-09-02
Trial ID
NCT04401995
Treatments Being Tested